ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $40,000 | -77.0% | 41,000 | -80.0% | 0.00% | – |
| Q1 2017 | $174,000 | +1640.0% | 205,000 | +1476.9% | 0.00% | – |
| Q4 2016 | $10,000 | -69.7% | 13,000 | -67.5% | 0.00% | – |
| Q3 2016 | $33,000 | -99.2% | 40,000 | -99.1% | 0.00% | -100.0% |
| Q2 2016 | $3,994,000 | +275.7% | 4,571,000 | +334.5% | 0.01% | +400.0% |
| Q2 2015 | $1,063,000 | -91.7% | 1,052,000 | -91.6% | 0.00% | -93.3% |
| Q1 2015 | $12,798,000 | +1356.0% | 12,547,000 | +1542.3% | 0.02% | +1400.0% |
| Q4 2014 | $879,000 | -57.5% | 764,000 | -61.9% | 0.00% | -50.0% |
| Q3 2014 | $2,067,000 | – | 2,007,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |